17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes.

[1]  P. Kushner,et al.  Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells , 2008, Breast Cancer Research and Treatment.

[2]  C. Maric,et al.  17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling. , 2007, American journal of physiology. Renal physiology.

[3]  Alicja Wolk,et al.  Diabetes mellitus and risk of breast cancer: A meta‐analysis , 2007, International journal of cancer.

[4]  K. Korach,et al.  Gender-specific effects of endogenous testosterone: female alpha-estrogen receptor-deficient C57Bl/6J mice develop glomerulosclerosis. , 2007, Kidney international.

[5]  S. Shankland,et al.  Podocytes in culture: past, present, and future. , 2007, Kidney international.

[6]  Andreas Beyer,et al.  Posttranscriptional Expression Regulation: What Determines Translation Rates? , 2007, PLoS Comput. Biol..

[7]  J. Rogers,et al.  Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[8]  G. Striker,et al.  Smoking induces glomerulosclerosis in aging estrogen-deficient mice through cross-talk between TGF-beta1 and IGF-I signaling pathways. , 2006, Journal of the American Society of Nephrology : JASN.

[9]  R. Kalluri.  Proteinuria with and without renal glomerular podocyte effacement. , 2006, Journal of the American Society of Nephrology : JASN.

[10]  G. Remuzzi,et al.  Beneficial Effect of TGFβ Antagonism in Treating Diabetic Nephropathy Depends on When Treatment Is Started , 2006, Nephron Experimental Nephrology.

[11]  G. Striker,et al.  Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: modulation of the mesangial cell phenotype in vivo. , 2006, The American journal of pathology.

[12]  S. Shankland,et al.  The podocyte's response to injury: role in proteinuria and glomerulosclerosis. , 2006, Kidney international.

[13]  D. Wallace,et al.  Functional estrogen receptors in the mitochondria of breast cancer cells. , 2006, Molecular biology of the cell.

[14]  D. Clapham,et al.  TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function , 2005, Nature Genetics.

[15]  Suzanne M. Johnson,et al.  Influence of oestradiol and tamoxifen on oestrogen receptors-α and -β protein degradation and non-genomic signalling pathways in uterine and breast carcinoma cells , 2005 .

[16]  C. Ecelbarger,et al.  Diabetic nephropathy is associated with decreased circulating estradiol levels and imbalance in the expression of renal estrogen receptors. , 2005, Gender medicine.

[17]  A. Mauviel,et al.  Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β: implications for carcinogenesis , 2005, Oncogene.

[18]  G. Wolf,et al.  Angiotensin II stimulates α3(IV) collagen production in mouse podocytes via TGF-β and VEGF signalling: implications for diabetic glomerulopathy , 2005 .

[19]  G. Wolf,et al.  From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. , 2005, Diabetes.

[20]  H. Werner,et al.  Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cells. , 2005, Endocrinology.

[21]  C. Maric,et al.  17beta-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy. , 2005, American journal of physiology. Renal physiology.

[22]  T. Wada,et al.  Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  Joel A. Blush,et al.  Estradiol reverses renal injury in Alb/TGF-β1 transgenic mice , 2004 .

[24]  C. Hinojosa-Laborde,et al.  Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat. , 2004, Journal of the American Society of Nephrology : JASN.

[25]  F. Ziyadeh.  Mediators of Diabetic Renal Disease: The Case for TGF-β as the Major Mediator , 2004 .

[26]  L. Barisoni,et al.  Podocyte Biology and the Emerging Understanding of Podocyte Diseases , 2003, American Journal of Nephrology.

[27]  L. Zacharia,et al.  Catecholamines Block the Antimitogenic Effect of Estradiol on Human Glomerular Mesangial Cells , 2003, Hypertension.

[28]  H. Schnaper,et al.  Cross‐talk between ERK MAP kinase and Smad‐signaling pathways enhances TGF‐β dependent responses in human mesangial cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  G. Striker,et al.  Resistance to glomerulosclerosis in B6 mice disappears after menopause. , 2003, The American journal of pathology.

[30]  G. Striker,et al.  Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens. , 2002, The American journal of pathology.

[31]  L. Zacharia,et al.  Role of Methoxyestradiols in the Growth Inhibitory Effects of Estradiol on Human Glomerular Mesangial Cells , 2002, Hypertension.

[32]  F. Kern,et al.  Hyperactivation of MAPK Induces Loss of ERα Expression in Breast Cancer Cells , 2001 .

[33]  P. Hervé,et al.  Preservation of the myofibroblastic phenotype of human papilloma virus 16 E6/E7 immortalized human bone marrow cells using the lineage limited alpha-smooth muscle actin promoter. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[34]  G. Striker,et al.  Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. , 2001, Journal of the American Society of Nephrology : JASN.

[35]  S. Goldfarb,et al.  TGF-beta: a crucial component of the pathogenesis of diabetic nephropathy. , 2001, Transactions of the American Clinical and Climatological Association.

[36]  B. Chiang,et al.  Tamoxifen Decreases Renal Inflammation and Alleviates Disease Severity in Autoimmune NZB/W F1 Mice , 2000, Scandinavian journal of immunology.

[37]  Z. Vajo,et al.  Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension , 2000, BJOG : an international journal of obstetrics and gynaecology.

[38]  S. Silbiger,et al.  Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. , 2000, American journal of physiology. Renal physiology.

[39]  W. Stetler-Stevenson,et al.  Matrix metalloproteinases in renal development and disease. , 2000, Journal of the American Society of Nephrology : JASN.

[40]  S. Silbiger,et al.  Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade. , 1999, American journal of physiology. Renal physiology.

[41]  S. Hubchak,et al.  TGF-beta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. , 1999, Kidney international.

[42]  R. G. Nelson,et al.  Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria , 1999, Diabetologia.

[43]  G. Striker,et al.  Mesangial cells from transgenic mice with progressive glomerulosclerosis exhibit stable, phenotypic changes including undetectable MMP-9 and increased type IV collagen. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[44]  S. Silbiger,et al.  Effects of sex hormones on mesangial cell proliferation and collagen synthesis. , 1996, Kidney international.

[45]  G. Striker,et al.  Dissociation of glomerular hypertrophy, cell proliferation, and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. , 1996, The Journal of clinical investigation.

[46]  C. Nast,et al.  Expression of transforming growth factor-β isoforms in human glomerular diseases , 1996 .

[47]  A. Varki.  The times they are still a'changing: keeping up with the times. , 1996, The Journal of clinical investigation.

[48]  J. V. van Mourik,et al.  Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirus containing human papilloma virus 16 E6/E7 DNA. , 1995, Experimental cell research.

[49]  C. Finch,et al.  Natural history and mechanisms of reproductive aging in humans, laboratory rodents, and other selected vertebrates. In: Knobil E, Neill JD, eds. , 1994 .

[50]  J. Liehr,et al.  Localization of estrogen receptors in interstitial cells of hamster kidney and in estradiol-induced renal tumors as evidence of the mesenchymal origin of this neoplasm. , 1993, Cancer research.

[51]  G. Striker,et al.  Mesangial cells from diabetic NOD mice constitutively secrete increased amounts of insulin-like growth factor-I. , 1993, Endocrinology.

[52]  E Ruoslahti,et al.  Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[53]  G. Striker,et al.  Glomerular epithelial, mesangial, and endothelial cell lines from transgenic mice. , 1988, Kidney international.